Publications
A QTWiST Analysis of Glasdegib Plus Low‐Dose Cytarabine Versus Low‐Dose Cytarabine as Initial Therapy for Acute Myeloid Leukemia in Patients Who Are Not Considered Candidates for Intensive ChemotherapyPublications
Explore the expertise, insights, and perspectives from OPEN Health that help transform complexity into clarity across today’s healthcare landscape.